Correlation Between Merck and Telo Genomics

Can any of the company-specific risk be diversified away by investing in both Merck and Telo Genomics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Merck and Telo Genomics into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Merck Company and Telo Genomics Corp, you can compare the effects of market volatilities on Merck and Telo Genomics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Merck with a short position of Telo Genomics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Merck and Telo Genomics.

Diversification Opportunities for Merck and Telo Genomics

0.68

Correlation Coefficient

Merck  Telo Genomics

Poor diversification

The 3 months correlation between Merck and Telo is 0.68. Overlapping area represents the amount of risk that can be diversified away by holding Merck Company and Telo Genomics Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Telo Genomics Corp and Merck is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Merck Company are associated (or correlated) with Telo Genomics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Telo Genomics Corp has no effect on the direction of Merck i.e., Merck and Telo Genomics go up and down completely randomly.

Pair Corralation between Merck and Telo Genomics

Considering the 90-day investment horizon Merck Company is expected to under-perform the Telo Genomics. But the stock apears to be less risky and, when comparing its historical volatility, Merck Company is 11.91 times less risky than Telo Genomics. The stock trades about -0.19 of its potential returns per unit of risk. The Telo Genomics Corp is currently generating about 0.04 of returns per unit of risk over similar time horizon. If you would invest  10.00  in Telo Genomics Corp on September 20, 2024 and sell it today you would lose (2.00) from holding Telo Genomics Corp or give up 20.0% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Significant
Accuracy	98.44%
Values	Daily Returns

Merck Company  vs.  Telo Genomics Corp

Merck Company

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Merck Company has generated negative risk-adjusted returns adding no value to investors with long positions. Despite uncertain performance in the last few months, the Stock's basic indicators remain quite persistent which may send shares a bit higher in January 2025. The latest mess may also be a sign of long-standing up-swing for the company institutional investors.

Telo Genomics Corp

Risk-Adjusted Performance

3 of 100

Insignificant

Compared to the overall equity markets, risk-adjusted returns on investments in Telo Genomics Corp are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. Despite nearly uncertain technical and fundamental indicators, Telo Genomics reported solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Merck and Telo Genomics

The main advantage of trading using opposite Merck and Telo Genomics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Merck position performs unexpectedly, Telo Genomics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Telo Genomics will offset losses from the drop in Telo Genomics' long position.

The idea behind Merck Company and Telo Genomics Corp pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Share Portfolio module to track or share privately all of your investments from the convenience of any device.